What is he best known for?
The fields of study he is best known for:
- Diabetes mellitus
- Internal medicine
- Type 2 diabetes
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Diabetes mellitus, Insulin and Type 2 diabetes.
His work in Carbohydrate metabolism, Postprandial, Glucagon, Kidney and Glucose uptake is related to Endocrinology.
His Carbohydrate metabolism research includes elements of Healthy subjects and Gluconeogenesis.
His research investigates the connection between Diabetes mellitus and topics such as Metabolism that intersect with issues in Carbohydrate.
His Insulin study incorporates themes from Stimulation, Pathogenesis and Pancreas.
His studies in Type 2 diabetes integrate themes in fields like Metformin and Pancreatic hormone.
His most cited work include:
- The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients (1313 citations)
- Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. (910 citations)
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) (734 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Endocrinology, Insulin, Diabetes mellitus and Type 2 diabetes.
His works in Hypoglycemia, Postprandial, Kidney, Glycemic and Glucose homeostasis are all subjects of inquiry into Internal medicine.
His is doing research in Glucagon, Carbohydrate metabolism, Gluconeogenesis, Insulin resistance and Metabolism, both of which are found in Endocrinology.
John E. Gerich combines subjects such as Somatostatin and Peptide hormone with his study of Glucagon.
John E. Gerich has researched Insulin in several fields, including Epinephrine and Arginine.
His work focuses on many connections between Diabetes mellitus and other disciplines, such as Risk factor, that overlap with his field of interest in Cardiology.
He most often published in these fields:
- Internal medicine (93.85%)
- Endocrinology (87.69%)
- Insulin (46.15%)
What were the highlights of his more recent work (between 2006-2017)?
- Internal medicine (93.85%)
- Endocrinology (87.69%)
- Diabetes mellitus (44.10%)
In recent papers he was focusing on the following fields of study:
John E. Gerich mainly investigates Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Postprandial.
His studies deal with areas such as Gastroenterology, Type 2 Diabetes Mellitus and Intensive care medicine as well as Internal medicine.
Endocrinology is represented through his Insulin, Glucose homeostasis, Glucagon, Renal glucose reabsorption and Kidney research.
His Diabetes mellitus study combines topics from a wide range of disciplines, such as Body mass index, Disease, Pathogenesis and Risk factor.
His research integrates issues of Metformin, Cell and Physical therapy in his study of Type 2 diabetes.
His work deals with themes such as Glycated hemoglobin and Stomach, Gastric emptying, which intersect with Postprandial.
Between 2006 and 2017, his most popular works were:
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) (734 citations)
- Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD) (Diabetes Care (2009) 32, (1224-1230)) (296 citations)
- The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. (290 citations)
In his most recent research, the most cited papers focused on:
- Diabetes mellitus
- Internal medicine
- Type 2 diabetes
His primary scientific interests are in Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Postprandial.
His research on Internal medicine often connects related areas such as Glycerol.
Glucose homeostasis, Insulin, Gastric inhibitory polypeptide, Meal ingestion and Ketone bodies are subfields of Endocrinology in which his conducts study.
His research in Diabetes mellitus intersects with topics in Body mass index, Clinical trial, Risk factor and Intensive care medicine.
The various areas that he examines in his Type 2 diabetes study include Metformin, Pancreatic hormone and Type 2 Diabetes Mellitus.
He works mostly in the field of Postprandial, limiting it down to topics relating to Glycemic and, in certain cases, Gastroenterology and Pharmacotherapy, as a part of the same area of interest.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
